PMID: 9448273Mar 14, 1998Paper

The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal

Proceedings of the National Academy of Sciences of the United States of America
A PauseR D Klausner

Abstract

The inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene predisposes affected individuals to the human VHL cancer syndrome and is associated with sporadic renal cell carcinomas (RCC) and brain hemangioblastomas. VHL-negative 786-0 RCC cells are tumorigenic in nude mice which is suppressed by the reintroduction of VHL. Remarkably, this occurs without affecting the growth rate and cell cycle profile of these cells in culture. The 786-0 cell line, like many cancer cells, fails to exit the cell cycle upon serum withdrawal. Here, it is shown that reintroduction of the wild-type VHL gene restores the ability of VHL-negative RCC cancer cells to exit the cell cycle and enter G0/quiescence in low serum. Both VHL-positive and VHL-negative RCC cells exit the cell cycle by contact inhibition. The cyclin-dependent kinase inhibitor, p27, accumulates upon serum withdrawal, only in the presence of VHL, as a result of the stabilization of the protein. We propose that the loss of wild-type VHL gene results in a specific cellular defect in serum-dependent growth control, which may initiate tumor formation. This is corrected by the reintroduction of wild-type VHL, implicating VHL as the first tumor suppressor involved in the regulatio...Continue Reading

References

Apr 3, 1992·Cell·G I EvanD C Hancock
Nov 3, 1989·Science·A B Pardee
Aug 1, 1995·Nature Medicine·O IliopoulosW G Kaelin
Jul 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·D R DuanR D Klausner
May 15, 1995·Genes & Development·C J Sherr, J M Roberts
Dec 1, 1994·Current Opinion in Cell Biology·S J Elledge, J W Harper
May 1, 1994·Nature Genetics·J R GnarraF M Duh
Mar 18, 1996·Biochimica Et Biophysica Acta·J R GnarraW M Linehan
Aug 2, 1996·The Journal of Biological Chemistry·N RivardJ Pouysségur
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·A PauseR D Klausner

❮ Previous
Next ❯

Citations

Sep 19, 2008·JAMA : the Journal of the American Medical Association·John A ButmanRussell R Lonser
Jul 2, 2005·Virchows Archiv : an International Journal of Pathology·Derek John AtkinsStephan Störkel
May 11, 2011·International Journal of Clinical Oncology·Yushi ZhaoZhong-Zheng Zhu
Mar 17, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·María J Calzada
Nov 30, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wani Arjumand, Sarwat Sultana
Dec 3, 1999·Progress in Biophysics and Molecular Biology·K L Craig, M Tyers
Jun 20, 2003·Lancet·Russell R LonserEdward H Oldfield
Feb 19, 2000·Current Opinion in Genetics & Development·K Macleod
Jan 1, 2003·Seminars in Cancer Biology·Christopher William Pugh, Peter John Ratcliffe
Oct 3, 2002·Molecular Genetics and Metabolism·Kathleen M Sakamoto
Jun 15, 1999·Molecular Medicine Today·M Ohh, W G Kaelin
Jun 22, 2002·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Ro Ra OhWon Sang Park
Dec 24, 2005·Nature Reviews. Cancer·Benjamin D Rowland, Daniel S Peeper
Oct 17, 2008·Nature Reviews. Cancer·William G Kaelin
Apr 7, 2010·Nature Reviews. Clinical Oncology·Lucy Gossage, Tim Eisen
Jul 25, 2000·BJU International·K J Turner
Sep 25, 2012·Human Molecular Genetics·Rebecca L FoyHerbert T Cohen
Jun 23, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jennifer D CohenSerrine S Lau
Apr 14, 2006·Biology of Reproduction·Francesca IettaIsabella Caniggia
Aug 24, 1999·Current Opinion in Nephrology and Hypertension·H T Cohen
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·W G Kaelin
Jun 22, 2002·Molecular and Cellular Biology·Binghui LiKristin T Chun
Apr 20, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·S GläskerH P Neumann
Jun 29, 2000·Annual Review of Biochemistry·J W Conaway, R C Conaway
Nov 28, 2007·Annual Review of Pathology·William G Kaelin
Jun 9, 2000·Annual Review of Physiology·A O HoffR F Gagel
Jan 5, 2002·Journal of Neurosurgery·L S GovernaleE H Oldfield
Dec 18, 2013·Indian Journal of Human Genetics·Pasupuleti Santhosh KumarBobbidi Venkata Phaneendra
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·D LiakopoulosA Pause
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·M Tyers, R Rottapel
Jul 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mina I ZhouHerbert T Cohen
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·T SoucekM Hengstschläger
Aug 15, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Gianluigi MazzoccoliManlio Vinciguerra
Jul 17, 2014·Virchows Archiv : an International Journal of Pathology·Mariana Rezende AlvesRafael Malagoli Rocha
Feb 13, 2001·Current Opinion in Genetics & Development·M Ivan, W G Kaelin
Dec 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Aleksandra FranovicStephen Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.